X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8713) 8713
Dissertation (60) 60
Newsletter (56) 56
Newspaper Article (54) 54
Publication (39) 39
Magazine Article (20) 20
Book Chapter (12) 12
Conference Proceeding (6) 6
Web Resource (4) 4
Journal / eJournal (2) 2
Paper (2) 2
Book Review (1) 1
Streaming Video (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (5215) 5215
life sciences & biomedicine (5037) 5037
losartan (4591) 4591
male (4433) 4433
animals (4131) 4131
humans (3364) 3364
rats (2898) 2898
losartan - pharmacology (2882) 2882
female (2144) 2144
losartan - therapeutic use (2090) 2090
angiotensin receptor antagonists (1974) 1974
blood pressure - drug effects (1659) 1659
cardiovascular system & cardiology (1645) 1645
hypertension - drug therapy (1514) 1514
imidazoles - pharmacology (1499) 1499
middle aged (1391) 1391
angiotensin ii (1357) 1357
hypertension (1346) 1346
antihypertensive agents - therapeutic use (1306) 1306
pharmacology & pharmacy (1289) 1289
tetrazoles - pharmacology (1269) 1269
antihypertensive agents - pharmacology (1178) 1178
rats, sprague-dawley (1162) 1162
angiotensin ii - pharmacology (1145) 1145
angiotensin (1131) 1131
peripheral vascular disease (1122) 1122
biphenyl compounds - pharmacology (1057) 1057
angiotensin ii type 1 receptor blockers - pharmacology (1048) 1048
aged (1005) 1005
adult (929) 929
losartan - administration & dosage (855) 855
rats, wistar (829) 829
cardiac & cardiovascular systems (784) 784
angiotensin ii - metabolism (736) 736
angiotensin ii - antagonists & inhibitors (734) 734
hypertension - physiopathology (734) 734
angiotensin ii type 1 receptor blockers - therapeutic use (713) 713
dose-response relationship, drug (685) 685
blood pressure (679) 679
physiology (679) 679
treatment outcome (656) 656
receptor, angiotensin, type 1 (613) 613
pyridines - pharmacology (605) 605
renin-angiotensin system - drug effects (575) 575
angiotensin-converting enzyme inhibitors - pharmacology (568) 568
angiotensin-converting enzyme inhibitors - therapeutic use (564) 564
time factors (550) 550
mice (529) 529
abridged index medicus (527) 527
disease models, animal (514) 514
drug therapy, combination (502) 502
double-blind method (493) 493
urology & nephrology (479) 479
tetrazoles - therapeutic use (450) 450
receptors, angiotensin - metabolism (449) 449
antihypertensive agents - administration & dosage (443) 443
receptor, angiotensin, type 1 - metabolism (436) 436
cells, cultured (432) 432
receptor, angiotensin, type 2 (432) 432
renin-angiotensin system (427) 427
drug therapy (421) 421
kidney - drug effects (406) 406
angiotensin ii - physiology (403) 403
hypertension - complications (401) 401
research (401) 401
rats, inbred shr (399) 399
losartan - adverse effects (391) 391
heart rate - drug effects (379) 379
in vitro techniques (373) 373
physiological aspects (371) 371
renin-angiotensin system - physiology (342) 342
general & internal medicine (338) 338
receptors, angiotensin - physiology (334) 334
risk factors (324) 324
medicine, general & internal (321) 321
biphenyl compounds - therapeutic use (320) 320
endocrinology & metabolism (318) 318
antihypertensive agents - adverse effects (315) 315
hemodynamics - drug effects (303) 303
rodents (301) 301
blood pressure - physiology (294) 294
analysis (293) 293
angiotensin ii type 1 receptor blockers - administration & dosage (292) 292
receptors (287) 287
valsartan (285) 285
biochemistry & molecular biology (281) 281
medicine, research & experimental (275) 275
imidazoles - therapeutic use (274) 274
losartan potassium (273) 273
neurosciences & neurology (270) 270
research & experimental medicine (269) 269
neurosciences (267) 267
cardiovascular system (265) 265
heart failure - drug therapy (263) 263
kidney - metabolism (260) 260
heart failure (258) 258
rna, messenger - metabolism (257) 257
captopril - pharmacology (252) 252
hypertension - metabolism (247) 247
medicine (245) 245
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8453) 8453
Japanese (138) 138
Russian (130) 130
Chinese (129) 129
German (92) 92
Portuguese (90) 90
Spanish (69) 69
French (39) 39
Italian (28) 28
Korean (14) 14
Polish (14) 14
Danish (13) 13
Turkish (10) 10
Czech (9) 9
Dutch (9) 9
Swedish (9) 9
Hungarian (7) 7
Ukrainian (6) 6
Persian (5) 5
Norwegian (4) 4
Serbian (4) 4
Slovak (4) 4
Croatian (3) 3
Hebrew (2) 2
Finnish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 07/2009, Volume 361, Issue 1, pp. 40 - 51
This study aimed to determine whether early administration of drugs that block the renin–angiotensin system slows the progression of change in glomerular... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Retina - drug effects | Angiotensin II Type 1 Receptor Blockers - adverse effects | Follow-Up Studies | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Male | Albuminuria | Angiotensin II Type 1 Receptor Blockers - pharmacology | Enalapril - therapeutic use | Enalapril - adverse effects | Mesangial Cells - drug effects | Glomerular Filtration Rate - drug effects | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Adult | Female | Angiotensin-Converting Enzyme Inhibitors - pharmacology | Diabetic Nephropathies - prevention & control | Double-Blind Method | Diabetes Mellitus, Type 1 - physiopathology | Kidney Glomerulus - drug effects | Diabetes Mellitus, Type 1 - pathology | Kaplan-Meier Estimate | Losartan - pharmacology | Logistic Models | Kidney Glomerulus - pathology | Disease Progression | Diabetes Mellitus, Type 1 - drug therapy | Diabetic Retinopathy - prevention & control | Enalapril - pharmacology | Losartan - therapeutic use | Mesangial Cells - pathology | Losartan - adverse effects | Renin-Angiotensin System - drug effects | Retina - pathology | Diabetic retinopathy | Control | Usage | Enalapril | Type 1 diabetes | Patient outcomes | Losartan | Enalaprilat | Drug therapy | Kidneys | Diabetes | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 11/2014, Volume 371, Issue 22, pp. 2061 - 2071
Journal Article
The New England journal of medicine, ISSN 1533-4406, 06/2008, Volume 358, Issue 23, pp. 2433 - 2446
Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 1091-6490, 01/2011, Volume 108, Issue 7, pp. 2909 - 2914
The dense collagen network in tumors significantly reduces the penetration and efficacy of nanotherapeutics. We tested whether losartan—a clinically approved... 
Nanoparticles | Receptors | Medical treatment | Collagens | Antineoplastics | Viruses | Dosage | Pancreatic neoplasms | Tumors | Cancer | Thrombospondin-1 | Drug delivery | Transport | Transforming growth factor β | Matrix modifier | Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Immunohistochemistry | Skin Neoplasms - drug therapy | Fluorescence Recovery After Photobleaching | Humans | DNA Primers - genetics | Dose-Response Relationship, Drug | Pancreatic Neoplasms - drug therapy | Doxorubicin - analogs & derivatives | Polymerase Chain Reaction | Female | Collagen - biosynthesis | Losartan - pharmacokinetics | Doxorubicin - administration & dosage | Carcinoma - drug therapy | Nanotechnology - methods | Losartan - pharmacology | Mice, SCID | Breast Neoplasms - drug therapy | Polyethylene Glycols - administration & dosage | Oncolytic Virotherapy - methods | Simplexvirus | Animals | Analysis of Variance | Mice | Drug Delivery Systems - methods | Drugs | Care and treatment | Drug delivery systems | Medical technology | Research | Properties | Vehicles | Medical laboratory technology | Collagen | Losartan | Nanotechnology | Proteins | Nanoscience | Pharmacology | Drug therapy | Protein synthesis | Index Medicus | Biological Sciences | Physical Sciences | transforming growth factor β | drug delivery | transport | thrombospondin-1 | matrix modifier
Journal Article
Journal Article
Kidney international, ISSN 0085-2538, 03/2004, Volume 65, Issue 3, pp. 1041 - 1049
Journal Article
Clinical Therapeutics, ISSN 0149-2918, 2012, Volume 34, Issue 3, pp. 552 - 568.e9
Abstract Background Angiotensin receptor blockers (ARBs) is an effective and well tolerated first-line antihypertensive drug. Fimasartan is a newly developed... 
Internal Medicine | Medical Education | angiotensin receptor blocker | losartan | hypertension | fimasartan | active-control equivalence trial | Hypertension | Fimasartan | Angiotensin receptor blocker | Losartan | Active-control equivalence trial | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Antihypertensive Agents - pharmacology | Prospective Studies | Tetrazoles - pharmacology | Humans | Middle Aged | Angiotensin Receptor Antagonists - pharmacology | Antihypertensive Agents - administration & dosage | Biphenyl Compounds - adverse effects | Hypertension - drug therapy | Male | Biphenyl Compounds - therapeutic use | Dose-Response Relationship, Drug | Young Adult | Biphenyl Compounds - pharmacology | Adult | Female | Blood Pressure - drug effects | Hypertension - diagnosis | Republic of Korea | Severity of Illness Index | Double-Blind Method | Losartan - pharmacology | Treatment Outcome | Pyrimidines - pharmacology | Antihypertensive Agents - therapeutic use | Antihypertensive Agents - adverse effects | Pyrimidines - therapeutic use | Adolescent | Losartan - therapeutic use | Pyrimidines - adverse effects | Losartan - adverse effects | Tetrazoles - therapeutic use | Aged | Losartan - administration & dosage | Tetrazoles - adverse effects | Angiotensin Receptor Antagonists - therapeutic use | Angiotensin Receptor Antagonists - administration & dosage | Angiotensin Receptor Antagonists - adverse effects | Medical colleges | Angiotensin | Antihypertensive drugs | Clinical trials | Cardiology | Comparative analysis | Hospitals | Drug therapy | Colleges & universities | Pharmaceuticals | Index Medicus
Journal Article